Becton Dickinson and (BDX) revenue breakdown

Healthcare · Medical Instruments & Supplies · Market cap $50.4B

By segment, Medical is the largest at 52% of fiscal 2025 revenue; Interventional grew fastest, 25% a year over 9 years.

By region, United States is the largest at 59% of fiscal 2025 revenue; Other grew fastest, 9% a year over 5 years.

Revenue by segment

Fiscal years, as Becton Dickinson and reports them in its 10-K filings; fiscal 2025 total $21.8B.

Segments2016201720182019202020212022202320242025Share
Medical$8.0B$7.4B$8.6B$9.1B$7.6B$8.4B$8.8B$9.5B$10.1B$11.5B 52%
Interventional$689M$685M$3.0B$3.9B$3.8B$4.2B$4.5B$4.7B$5.0B$5.2B 24%
Life Sciences$3.8B$4.0B$4.3B$4.3B$4.7B$6.5B$5.6B$5.1B$5.2B$5.2B 24%

Revenue by region

Fiscal years, as Becton Dickinson and reports them in its 10-K filings; fiscal 2025 total $21.8B.

Regions2016201720182019202020212022202320242025Share
United States$6.9B$6.5B$8.8B$9.7B$9.2B$10.4B$10.7B$11.1B$11.7B$12.8B 59%
EMEA————$3.7B$4.5B$4.0B$4.2B$4.4B$4.7B 22%
Greater Asia————$2.4B$3.1B$3.0B$2.9B$2.9B$3.1B 14%
Other————$794M$1.1B$1.1B$1.1B$1.2B$1.2B 6%
Non-US———$7.6B—————— —
Europe$2.7B$2.6B$3.3B——————— —
Greater Asia$1.7B$1.7B$2.5B——————— —
Other$1.2B$1.3B$1.5B——————— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BDX.
Open BDX in Investingly

Questions

Where does Becton Dickinson and make its money?

In fiscal 2025, by segment: Medical $11.5B, Interventional $5.2B, Life Sciences $5.2B.

From Becton Dickinson and's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.